Cargando…
The cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study
BACKGROUND: Cisplatin-induced acute kidney injury (AKI) is common during preoperative chemotherapy for esophageal cancer. The purpose of this study was to investigate the association between AKI after preoperative chemotherapy and postoperative complications in patients with esophageal cancer. METHO...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044717/ https://www.ncbi.nlm.nih.gov/pubmed/36973771 http://dx.doi.org/10.1186/s12893-023-01949-0 |
_version_ | 1784913415317225472 |
---|---|
author | Ueno, Shuhei Murashima, Miho Ogawa, Ryo Saito, Masaki Ito, Sunao Hayakawa, Shunsuke Okubo, Tomotaka Sagawa, Hiroyuki Tanaka, Tatsuya Takahashi, Hiroki Matsuo, Yoichi Mitsui, Akira Kimura, Masahiro Hamano, Takayuki Takiguchi, Shuji |
author_facet | Ueno, Shuhei Murashima, Miho Ogawa, Ryo Saito, Masaki Ito, Sunao Hayakawa, Shunsuke Okubo, Tomotaka Sagawa, Hiroyuki Tanaka, Tatsuya Takahashi, Hiroki Matsuo, Yoichi Mitsui, Akira Kimura, Masahiro Hamano, Takayuki Takiguchi, Shuji |
author_sort | Ueno, Shuhei |
collection | PubMed |
description | BACKGROUND: Cisplatin-induced acute kidney injury (AKI) is common during preoperative chemotherapy for esophageal cancer. The purpose of this study was to investigate the association between AKI after preoperative chemotherapy and postoperative complications in patients with esophageal cancer. METHODS: In this retrospective cohort study, we included patients who had received preoperative chemotherapy with cisplatin and underwent surgical resection for esophageal cancer under general anesthesia from January 2017 to February 2022 at an education hospital. A predictor was stage 2 or higher cisplatin-induced AKI (c-AKI) defined by the KDIGO criteria within 10 days after chemotherapy. Outcomes were postoperative complications and length of hospital stays. Associations between c-AKI and outcomes including postoperative complications and length of hospital stays were examined with logistic regression models. RESULTS: Among 101 subjects, 22 developed c-AKI with full recovery of the estimated glomerular filtration (eGFR) before surgery. Demographics were not significantly different between patients with and without c-AKI. Patients with c-AKI had significantly longer hospital stays than those without c-AKI [mean (95% confidence interval (95%CI)) 27.6 days (23.3–31.9) and 43.8 days (26.5–61.2), respectively, mean difference (95%CI) 16.2 days (4.4–28.1)]. Those with c-AKI had higher C-reactive protein (CRP) levels and prolonged weight gain after surgery and before the events of interest despite having comparable eGFR trajectories after surgery. c-AKI was significantly associated with anastomotic leakage and postoperative pneumonia [odds ratios (95%CI) 4.14 (1.30–13.18) and 3.87 (1.35–11.0), respectively]. Propensity score adjustment and inverse probability weighing yielded similar results. Mediation analysis showed that a higher incidence of anastomotic leakage in patients with c-AKI was primarily mediated by CRP levels (mediation percentage 48%). CONCLUSION: c-AKI after preoperative chemotherapy in esophageal cancer patients was significantly associated with the development of postoperative complications and led to a resultant longer hospital stay. Increased vascular permeability and tissue edema due to prolonged inflammation might explain the mechanisms for the higher incidence of postoperative complications. |
format | Online Article Text |
id | pubmed-10044717 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-100447172023-03-29 The cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study Ueno, Shuhei Murashima, Miho Ogawa, Ryo Saito, Masaki Ito, Sunao Hayakawa, Shunsuke Okubo, Tomotaka Sagawa, Hiroyuki Tanaka, Tatsuya Takahashi, Hiroki Matsuo, Yoichi Mitsui, Akira Kimura, Masahiro Hamano, Takayuki Takiguchi, Shuji BMC Surg Research BACKGROUND: Cisplatin-induced acute kidney injury (AKI) is common during preoperative chemotherapy for esophageal cancer. The purpose of this study was to investigate the association between AKI after preoperative chemotherapy and postoperative complications in patients with esophageal cancer. METHODS: In this retrospective cohort study, we included patients who had received preoperative chemotherapy with cisplatin and underwent surgical resection for esophageal cancer under general anesthesia from January 2017 to February 2022 at an education hospital. A predictor was stage 2 or higher cisplatin-induced AKI (c-AKI) defined by the KDIGO criteria within 10 days after chemotherapy. Outcomes were postoperative complications and length of hospital stays. Associations between c-AKI and outcomes including postoperative complications and length of hospital stays were examined with logistic regression models. RESULTS: Among 101 subjects, 22 developed c-AKI with full recovery of the estimated glomerular filtration (eGFR) before surgery. Demographics were not significantly different between patients with and without c-AKI. Patients with c-AKI had significantly longer hospital stays than those without c-AKI [mean (95% confidence interval (95%CI)) 27.6 days (23.3–31.9) and 43.8 days (26.5–61.2), respectively, mean difference (95%CI) 16.2 days (4.4–28.1)]. Those with c-AKI had higher C-reactive protein (CRP) levels and prolonged weight gain after surgery and before the events of interest despite having comparable eGFR trajectories after surgery. c-AKI was significantly associated with anastomotic leakage and postoperative pneumonia [odds ratios (95%CI) 4.14 (1.30–13.18) and 3.87 (1.35–11.0), respectively]. Propensity score adjustment and inverse probability weighing yielded similar results. Mediation analysis showed that a higher incidence of anastomotic leakage in patients with c-AKI was primarily mediated by CRP levels (mediation percentage 48%). CONCLUSION: c-AKI after preoperative chemotherapy in esophageal cancer patients was significantly associated with the development of postoperative complications and led to a resultant longer hospital stay. Increased vascular permeability and tissue edema due to prolonged inflammation might explain the mechanisms for the higher incidence of postoperative complications. BioMed Central 2023-03-27 /pmc/articles/PMC10044717/ /pubmed/36973771 http://dx.doi.org/10.1186/s12893-023-01949-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ueno, Shuhei Murashima, Miho Ogawa, Ryo Saito, Masaki Ito, Sunao Hayakawa, Shunsuke Okubo, Tomotaka Sagawa, Hiroyuki Tanaka, Tatsuya Takahashi, Hiroki Matsuo, Yoichi Mitsui, Akira Kimura, Masahiro Hamano, Takayuki Takiguchi, Shuji The cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study |
title | The cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study |
title_full | The cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study |
title_fullStr | The cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study |
title_full_unstemmed | The cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study |
title_short | The cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study |
title_sort | cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044717/ https://www.ncbi.nlm.nih.gov/pubmed/36973771 http://dx.doi.org/10.1186/s12893-023-01949-0 |
work_keys_str_mv | AT uenoshuhei thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT murashimamiho thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT ogawaryo thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT saitomasaki thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT itosunao thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT hayakawashunsuke thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT okubotomotaka thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT sagawahiroyuki thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT tanakatatsuya thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT takahashihiroki thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT matsuoyoichi thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT mitsuiakira thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT kimuramasahiro thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT hamanotakayuki thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT takiguchishuji thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT uenoshuhei cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT murashimamiho cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT ogawaryo cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT saitomasaki cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT itosunao cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT hayakawashunsuke cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT okubotomotaka cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT sagawahiroyuki cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT tanakatatsuya cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT takahashihiroki cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT matsuoyoichi cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT mitsuiakira cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT kimuramasahiro cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT hamanotakayuki cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy AT takiguchishuji cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy |